Open access · CC-BY
via OpenAlex
The role and its mechanism of intermittent fasting in tumors: friend or foe?
Xu Zhao, Jing Yang, Ruoyu Huang, Mengmeng Guo, Ya Zhou, Lin Xu
Cancer Biology and Medicine · 2021 · ▲ 47 citations
Abstract
Intermittent fasting (IF) is becoming a prevailing topic worldwide, as it can cause changes in the body's energy metabolism processes, improve health, and affect the progression of many diseases, particularly in the circumstance of oncology. Recent research has shown that IF can alter the energy metabolism of tumor cells, thereby inhibiting tumor growth and improving antitumor immune responses. Furthermore, IF can increase cancer sensitivity to chemotherapy and radiotherapy and reduce the side effects of these traditional anticancer treatments. IF is therefore emerging as a promising approach to clinical cancer treatment. However, the balance between long-term benefits of IF compared with the harm from insufficient caloric intake is not well understood. In this article, we review the role of IF in tumorigenesis and tumor therapy, and discuss some scientific problems that remain to be clarified, which might provide some assistance in the application of IF in clinical tumor therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.20892/j.issn.2095-3941.2020.0250
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Zhao, X., Yang, J., Huang, R., Guo, M., Zhou, Y., & Xu, L. (2021). The role and its mechanism of intermittent fasting in tumors: friend or foe?. <em>Cancer Biology and Medicine</em>. https://doi.org/10.20892/j.issn.2095-3941.2020.0250
Vancouver
Zhao X, Yang J, Huang R, Guo M, Zhou Y, Xu L. The role and its mechanism of intermittent fasting in tumors: friend or foe?. Cancer Biology and Medicine. 2021. doi:10.20892/j.issn.2095-3941.2020.0250.
BibTeX
@article{xu2021Therol,
title = {The role and its mechanism of intermittent fasting in tumors: friend or foe?},
author = {Xu Zhao and Jing Yang and Ruoyu Huang and Mengmeng Guo and Ya Zhou and Lin Xu},
journal = {Cancer Biology and Medicine},
year = {2021},
doi = {10.20892/j.issn.2095-3941.2020.0250},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cancer Science 2022
Open access · CC-BY
Effect of fasting on cancer: A narrative review of scientific evidence
Aichi Cancer Center 2004
Open access · US-GOV
Multi-Institutional Phase II Study of Weekly Docetaxel and Concurrent Radiotherapy for Laryngeal and Hypopharyngeal Cancer in the Group of Elderly and/or Patients With Medical Illness
Barbara Ann Karmanos Cancer Institute 2008
Open access · US-GOV
Evaluation of Bevacizumab and Weekly Docetaxel in Elderly (≥ 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
JNCI Journal of the National Cancer Institute 2021
Open access · CC-BY
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
Cancer Cell 2025
Open access · CC-BY
Senescence in cancer
Roswell Park Cancer Institute 2006
Open access · US-GOV